Role of Angiogenenic Growth Factors In Psoriasis: A Review.
CONCLUSION: Anti-angiogenesis therapies targeting vaso-proliferation may represent a valid approach for the development of anti-psoriatic drugs and further development in this field can pave a way to new fields of treatment which could be complementary to those directly targeting inflammation.
PMID: 29663878 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Akhtar T, Wani WY, Kamal MA, Kaur R Tags: Curr Drug Metab Source Type: research
More News: Autoimmune Disease | Dermatology | Drugs & Pharmacology | Environmental Health | Psoriasis | Skin